Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Early Phase 1
1(20.0%)
Phase 2
1(20.0%)
5Total
N/A(3)
Early Phase 1(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07343908Not ApplicableNot Yet Recruiting

Impact of Chia Seeds on Human Breast Milk Composition

Role: collaborator

NCT07534332Phase 2Not Yet Recruiting

Disulfiram in Rheumatoid Arthritis

Role: collaborator

NCT07146893Early Phase 1Not Yet Recruiting

Feasibility Study for Repurposing RET Inhibitors

Role: collaborator

NCT06617520Not ApplicableCompleted

Attitudes and Smoking Perceptions in the Real Environment

Role: collaborator

NCT05600465Not ApplicableRecruiting

Behavioral Activation + Occupational Therapy: An Innovative Intervention for Empowered Self-Management of Multiple Chronic Conditions

Role: collaborator

All 5 trials loaded